This Study Aims to Assess the Impact of 50°C Saline Irrigation on the Overall Intraoperative Blood Loss and Surgical Visualization During Endoscopic Sinus Surgery for Rhinosinusitis.
Hot Saline Irrigation on Intraoperative Bleeding and Improving Surgical Field Visibility During Functional Endoscopic Sinus Surgery: a Prospective Clinical Study.
1 other identifier
interventional
59
1 country
1
Brief Summary
Objectives: Intraoperative bleeding during endoscopic sinus surgery for severe rhinosinusitis may significantly compromise the surgical field. Saline heated to 50°C promotes transient vessel vasodilation and mucosal edema without causing nasal mucosal necrosis. The brief thermal exposure may induce superficial protein denaturation and facilitate local hemostasis, thereby improving endoscopic visibility. This study aims to assess the impact of 50°C saline irrigation on the overall intraoperative blood loss and surgical visualization during endoscopic sinus surgery for rhinosinusitis. Methods: This prospective randomized controlled trial study is going to assign the patients to three groups. In the interventional hot saline group (HSI), intraoperative irrigation will be performed with heated saline at 50°C. In the room-temperature saline group (RTSI), saline at 22°C will be used; in the third one group (Control), no irrigation will be administered. Intraoperative blood loss will be recorded in milliliters and milliliters per minute of operative time, and the surgical field will be evaluated using the Boezaart scale. HSI is hypothesized to be more effective than RTSI in minimizing intraoperative bleeding during FESS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedJune 4, 2026
June 1, 2026
2.8 years
May 27, 2026
June 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total intraoperative bleeding
The effect of intraoperative irrigation with hot 0.9% NaCl on total intraoperative blood loss during FESS, compared with room-temperature NaCl irrigation and no irrigation, that will be measured in mililiters (ml).
From the beginning until the end of the surgery
Secondary Outcomes (2)
Surgical field visibility
From the beginning of the operation until the end.
The effect of intraoperative irrigation with hot 0.9% NaCl surgical field visibility and blood loss per minute of operative time during FESS, compared with room-temperature NaCl irrigation and no irrigation.
From the beginning to the end of surgery.
Study Arms (3)
Hot Saline Irrigation
EXPERIMENTALParticipants undergoing functional endoscopic sinus surgery (FESS) will receive intraoperative irrigation with 0.9% sodium chloride solution heated to 50°C at 10-minute intervals during surgery.
Room-Temperature Saline Irrigation
EXPERIMENTALParticipants undergoing FESS will receive intraoperative irrigation with 0.9% sodium chloride solution at room temperature (22°C).
Control Group
NO INTERVENTIONParticipants undergoing FESS without intraoperative saline irrigation.
Interventions
Intraoperative irrigation of the sinonasal cavity using 0.9% NaCl heated to 50°C during FESS.
Intraoperative irrigation of the sinonasal cavity using 0.9% NaCl at 22°C during FESS.
Eligibility Criteria
You may qualify if:
- Chronic rhinosinusitis diagnosed according to the EPOS 2020 criteria;
- Confirmed failure of conservative treatment, defined as persistence of CRS symptoms for more than 12 weeks despite optimal pharmacological therapy;
- Age over 18 years and ability to provide informed consent;
- Written informed consent to participate in the study;
- Presence of inflammatory changes on sinus computed tomography scans.
You may not qualify if:
- Lack of patient consent;
- Disease limited to a single sinus;
- Conditions associated with ciliary dyskinesia (e.g., cystic fibrosis);
- Suspected fungal infection or fungal ball;
- Poor adherence to medical recommendations or noncompliance with treatment;
- Suspected neoplastic disease;
- Suspected or confirmed autoimmune disorders, particularly granulomatosis with polyangiitis;
- \- Confirmed or clinically suspected immunodeficiency; Diagnosed coagulation disorders or preoperative hemostasis test results outside laboratory reference ranges; Preoperative systemic glucocorticosteroid therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Military Institute of Aviation Medicine
Warsaw, Mazovian, 01-755, Poland
Related Publications (4)
Altaf J, Ashfaq AH, Riaz N, Arshad M, Ayub N, Rehman A, Maqbool S. Effect of hot saline irrigation on the operative field during endoscopic sinus surgery: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2025 Jan;282(1):235-240. doi: 10.1007/s00405-024-09005-0. Epub 2024 Oct 1.
PMID: 39354187BACKGROUNDStangerup SE, Thomsen HK. Histological changes in the nasal mucosa after hot-water irrigation. An animal experimental study. Rhinology. 1996 Mar;34(1):14-7.
PMID: 8739861BACKGROUNDNagarajah D, Kueh YC, Lazim NM, Abdullah B. The hemostatic effect of hot saline irrigation in endoscopic sinus surgery: a systematic review and meta-analysis. Syst Rev. 2022 Nov 18;11(1):246. doi: 10.1186/s13643-022-02113-0.
PMID: 36401259BACKGROUNDAl-Qudah MA. The effect of intranasal irrigation with epinephrine solution on intraoperative visualization and bleeding during FESS. Eur Arch Otorhinolaryngol. 2022 Apr;279(4):1911-1917. doi: 10.1007/s00405-021-06952-w. Epub 2021 Jun 27.
PMID: 34175968BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnieszka Witkowska-Janik, MD, PhD
Military Institute of Aviation Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2026
First Posted
June 4, 2026
Study Start
March 1, 2023
Primary Completion
December 1, 2025
Study Completion
May 28, 2026
Last Updated
June 4, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data collected during the study will not be made publicly available.